Given our findings that macrophages show decreased ABCA1-mediated efflux upon reduction of PRMT2, studies that examine the effects of PRMT2 directly on atherosclerosis and diabetes are now warranted but beyond the scope of this study. This evidence concerns the gene PRMT2 and diabetes mellitus.